ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,213.49
0.51%
Dow Jones
38,675.68
1.18%
Gold vs US Dollar
2,302.57
0.00%
Brent Oil
82.765
0.00%
Bitcoin
63,460.15
-0.68%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Acurx Pharmaceuticals Inc (ACXP)

  7. Acurx Pharmaceuticals Inc (ACXP) News

Acurx Pharmaceuticals (ACXP)

Acurx Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ACXP
DateTimeSourceHeadlineSymbolCompany
02/05/202412:00PR Newswire (US)Acurx Pharmaceuticals Announces Presentation of Ibezapolstat Phase 2 Clinical Trial Results at ESCMID Global 2024 Scientific ConferenceNASDAQ:ACXPAcurx Pharmaceuticals Inc
25/04/202415:12PR Newswire (US)Acurx Pharmaceuticals Announces Presentation of Ibezapolostat Phase 2 Clinical Trial Results at upcoming ESCMID 2024 Scientific ConferenceNASDAQ:ACXPAcurx Pharmaceuticals Inc
23/04/202415:57PR Newswire (US)Acurx Pharmaceuticals, Inc. to Discuss First Quarter 2024 Financial Results on May 15, 2024 Conference Call and Provide Business UpdateNASDAQ:ACXPAcurx Pharmaceuticals Inc
19/03/202411:33IH Market NewsUnilever Initiates Ice Cream Division Spin-Off and Announces Job Cuts; Berkshire Ramps Up Share Buyback Efforts, and MoreNASDAQ:ACXPAcurx Pharmaceuticals Inc
18/03/202411:12IH Market NewsAnticipation Builds on Wall Street for Federal Reserve’s Upcoming Policy Moves; WTI and Brent See UpticksNASDAQ:ACXPAcurx Pharmaceuticals Inc
18/03/202411:01PR Newswire (US)Acurx Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2023 Results and Provides Business UpdateNASDAQ:ACXPAcurx Pharmaceuticals Inc
04/03/202412:01PR Newswire (US)Acurx Pharmaceuticals, Inc. to Discuss Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024 Conference Call and Provide Business UpdateNASDAQ:ACXPAcurx Pharmaceuticals Inc
27/02/202412:01PR Newswire (US)Acurx Announces FDA Has Granted an End of Phase 2 Meeting for Ibezapolstat for C. difficile Infection and the European Medicines Agency Granted SME Designation for Ibezapolstat EU DevelopmentNASDAQ:ACXPAcurx Pharmaceuticals Inc
23/02/202414:30GlobeNewswire Inc.New to The Street Announces Line-up of its Corporate Interviews Airing on its Leadership and Business Televised SeriesNASDAQ:ACXPAcurx Pharmaceuticals Inc
16/02/202414:30GlobeNewswire Inc.New to The Street Airs Episode 556 Featuring Five Corporate Interviews, Broadcast on the FOX Business Network Monday, February 19, 2024, at 10:30 PM PTNASDAQ:ACXPAcurx Pharmaceuticals Inc
02/02/202414:30GlobeNewswire Inc.New to The Street Announces its 553rd Episode TV Line Up, Featuring Five Corporate Guests, Airing on the FOX Business Network, Monday, February 5, 2024, 10:30 PM PTNASDAQ:ACXPAcurx Pharmaceuticals Inc
01/02/202414:33GlobeNewswire Inc.New to The Street TV Announces Episode #552 with its Five Business Guest Interviews, Airs on Bloomberg TV as Sponsored Programming, Tonight, February 1, 2024, at 9:30 PM PTNASDAQ:ACXPAcurx Pharmaceuticals Inc
29/01/202412:00PR Newswire (US)Acurx Announces Positive Extended Clinical Cure Data for Ibezapolstat from Phase 2b Clinical Trial in CDI PatientsNASDAQ:ACXPAcurx Pharmaceuticals Inc
26/01/202415:55GlobeNewswire Inc.New to The Street Announces Episode 551, Five Corporate Interviews, Airing on the FOX Business Network, Monday, January 29, 2024, at 10:30 PM PTNASDAQ:ACXPAcurx Pharmaceuticals Inc
23/01/202412:01PR Newswire (US)Acurx Pharmaceuticals to Present at the Microcap Conference, January 31, 2024 - February 1, 2024NASDAQ:ACXPAcurx Pharmaceuticals Inc
22/01/202411:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACXPAcurx Pharmaceuticals Inc
19/01/202414:30GlobeNewswire Inc.New to The Street Airs on the FOX Business Network, Episode 550, Featuring Six Corporate Interviews, Broadcast Monday, January 22, 2024, at 10:30 PM PTNASDAQ:ACXPAcurx Pharmaceuticals Inc
17/01/202412:01PR Newswire (US)Acurx Announces Positive Comparative Microbiology and Microbiome Data for Ibezapolstat from Phase 2b Clinical Trial in CDI PatientsNASDAQ:ACXPAcurx Pharmaceuticals Inc
05/01/202414:30GlobeNewswire Inc.New to The Street Announces its Four Corporate Interviews, Episode 543, Airing on the Fox Business Network, Monday, January 8, 2024, at 10:30 PM PTNASDAQ:ACXPAcurx Pharmaceuticals Inc
03/01/202413:00PR Newswire (US)Acurx to present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:ACXPAcurx Pharmaceuticals Inc
11/12/202312:01PR Newswire (US)Acurx Announces Positive Phase 2b Results Showing 100% of Patients Who Had Clinical Cure with Ibezapolstat Also Had Sustained Clinical CureNASDAQ:ACXPAcurx Pharmaceuticals Inc
08/12/202314:46GlobeNewswire Inc.New to The Street TV Features Five Corporate Guest Interviews, Episode 537 Airs on the FOX Business Network, Monday, December 11, 2023, at 10:30 PM PTNASDAQ:ACXPAcurx Pharmaceuticals Inc
07/12/202314:20GlobeNewswire Inc.New to The Street TV Announces Its Episode 536 Lineup, Five Corporate Guest Interviews, Broadcasted as Sponsored Program on Bloomberg TV, Tonight, Thursday, December 7, 2023, at 9:30 PM PTNASDAQ:ACXPAcurx Pharmaceuticals Inc
01/12/202314:30GlobeNewswire Inc.New to The Street Announces Five Corporate Interviews, Episode 535, Airing on the FOX Business Network on Monday, December 4, 2023, at 10:30 PM PTNASDAQ:ACXPAcurx Pharmaceuticals Inc
24/11/202314:30GlobeNewswire Inc.New to The Street Announces its Five Business Guest Interviews, Episode 533, Airs on the FOX Business Network on Monday, November 27, 2023, at 10:30 PM PTNASDAQ:ACXPAcurx Pharmaceuticals Inc
17/11/202314:30GlobeNewswire Inc.New to The Street Announces Episode 530 with Six Corporate Interviews, Airing on the Fox Business Network, Monday, November 20, 2023, at 10:30 PM PTNASDAQ:ACXPAcurx Pharmaceuticals Inc
15/11/202322:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACXPAcurx Pharmaceuticals Inc
15/11/202321:49Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ACXPAcurx Pharmaceuticals Inc
14/11/202312:01PR Newswire (US)Acurx Pharmaceuticals, Inc. Reports Third Quarter 2023 Results and Provides Business UpdateNASDAQ:ACXPAcurx Pharmaceuticals Inc
02/11/202311:01PR Newswire (US)Acurx Announces Positive Top-Line Ibezapolstat Phase 2 Efficacy Results with 96% Clinical Cure Rate in Patients with C. difficile InfectionNASDAQ:ACXPAcurx Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ACXP

Your Recent History

LSE
ALBA
Alba Mineral Resources
LSE
AGL
Angle
LSE
SRB
Serabi Gold
LSE
JUS
Jupiter Us Smaller Compa...
LSE
JET2
Jet2
LSE
TLW
Tullow Oil
LSE
APTA
Aptamer
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved